Pardon Bart, Hostens Miel, Duchateau Luc, Dewulf Jeroen, De Bleecker Koen, Deprez Piet
BMC Vet Res. 2013 Apr 15;9:79. doi: 10.1186/1746-6148-9-79.
Little is known on the effects of common calf diseases on mortality and carcass traits in the white veal industry (special-fed veal), a highly integrated production system, currently criticized for the intensive pro- and metaphylactic use of antimicrobials. The objective of the present study was to determine the impact of bovine respiratory disease (BRD), diarrhea, arthritis and otitis on the economically important parameters of mortality, hot carcass weight (HCW), carcass quality, fat cover and meat color. For this purpose, a prospective study on 3519 white veal calves, housed in 10 commercial herds, was conducted. Case definitions were based on clinical observation by the producers and written treatment records were used.
Calves received oral antimicrobial group treatments in the milk during 25.2% of the production time on average. With an increasing percentage of the production cycle spent on oral antimicrobials, HCW reduced, whereas the odds for insufficient fat cover or an undesirable red meat color both decreased. Of the calves, 14.8%, 5.3%, 1.5% and 1.6% were individually diagnosed and treated for BRD, diarrhea, arthritis and otitis, respectively. Overall, 5.7% of the calves died and the mortality risk was higher in the first weeks after arrival. Calves that experienced one BRD episode showed a 8.2 kg reduction in HCW, a lower fat cover and an increased mortality risk (hazard ratio (HR) = 5.5), compared to calves which were not individually diagnosed and treated for BRD. With an increasing number of BRD episodes, these losses increased dramatically. Additionally, calves, which experienced multiple BRD episodes, were more likely to have poor carcass quality and an undesirable red meat color at slaughter. Arthritis increased the mortality risk (HR = 3.9), and reduced HCW only when associated with BRD. Otitis did only increase the mortality risk (HR = 7.0). Diarrhea severely increased the mortality risk (HR = 11.0), reduced HCW by 9.2 kg on average and decreased carcass quality.
Despite the massive use of group and individual treatments to alleviate the most prevalent health issues at the fattening period, the effects of BRD, diarrhea, otitis and arthritis on survival and performance are still considerable, especially in cases of chronic pneumonia with or without arthritis. Controlling calf health by effective preventive and therapeutic strategies and in particular the prevention of chronic BRD is key for the profitability of veal operations.
在白色小牛肉产业(特殊饲养的小牛肉)中,关于常见犊牛疾病对死亡率和胴体性状的影响知之甚少。这是一个高度一体化的生产系统,目前因大量预防性和治疗性使用抗菌药物而受到批评。本研究的目的是确定牛呼吸道疾病(BRD)、腹泻、关节炎和中耳炎对死亡率、热胴体重(HCW)、胴体品质、脂肪覆盖度和肉色等经济重要参数的影响。为此,对10个商业牛群中饲养的3519头白色小牛肉犊牛进行了一项前瞻性研究。病例定义基于生产者的临床观察,并使用书面治疗记录。
犊牛在生产时间的25.2%平均接受了口服抗菌药物群体治疗。随着生产周期中用于口服抗菌药物的百分比增加,HCW降低,而脂肪覆盖不足或肉色不理想的几率均降低。分别有14.8%、5.3%、1.5%和1.6%的犊牛被单独诊断并治疗BRD、腹泻、关节炎和中耳炎。总体而言,5.7%的犊牛死亡,到达后的头几周死亡率风险更高。与未被单独诊断和治疗BRD的犊牛相比,经历一次BRD发作的犊牛HCW减少8.2千克,脂肪覆盖度降低,死亡率风险增加(风险比(HR)=5.5)。随着BRD发作次数增加,这些损失急剧增加。此外,经历多次BRD发作的犊牛在屠宰时更有可能胴体品质差且肉色不理想。关节炎增加了死亡率风险(HR=3.9),且仅在与BRD相关时降低HCW。中耳炎仅增加了死亡率风险(HR=7.0)。腹泻严重增加了死亡率风险(HR=11.0),平均使HCW降低9.2千克,并降低了胴体品质。
尽管在育肥期大量使用群体和个体治疗来缓解最普遍的健康问题,但BRD、腹泻、中耳炎和关节炎对存活和性能的影响仍然很大,特别是在伴有或不伴有关节炎的慢性肺炎病例中。通过有效的预防和治疗策略控制犊牛健康,尤其是预防慢性BRD,是小牛肉生产盈利的关键。